News & Resources

Strengthening digital approaches to improve HCP engagement strategies

In today’s healthcare landscape, strengthening your HCP engagement strategies through digital approaches is the biggest opportunity in pharma marketing.

Not to mention, multiple channels, especially online channels are the best way to connect with physicians. HCPs are typically pressed for time, have to deal with shrinking budgets, and want immediate access to valuable data. With an increasing number of developments in pharmaceuticals and clinical medicine, mobile channels are especially important, as they support critical communications and can host unlimited, targeted content.

Pharma marketers need to adapt and evolve if they are to provide value to their partners, like HCPs and other stakeholders. Digital channels for healthcare communications are efficient, convenient, and can actually alleviate the tremendous pressures most physicians experience daily. Digital marketing can even facilitate the innovation and discovery of new therapies, helping to advance healthcare initiatives.

Challenges of engagement
While face-to-face meetings are more and more difficult to secure, and because HCPs have already embraced current tech trends, it is to the benefit of pharma companies to strengthen their digital approaches to stakeholder and HCP engagement. While individuals today typically seek information from online resources first—physicians included—the challenge is providing high quality content that supports continual interaction with HCPs. In fact, HCPs rely on forms of electronic communication (such as emails, online forums, and mobile apps) to provide knowledge and assistance far more frequently than traditional information streams.

Most doctors feel the need to remain relevant among their peers, and the medical profession promotes a drive for excellence in research and clinical activities. Physicians are therefore among the most enthusiastic professionals to adopt their smartphone as a primary communication channel. The fact is that HCPs want to access the information they need, anytime they need it. For pharma companies looking to improve HCP engagement, they must evaluate their digital strategies and leverage state-of-the-art technology to make sure they meet the needs of their physician network.

Meeting your HCPs’ needs
As physicians are increasingly adopting mobile technology, there is a meaningful opportunity for pharma companies to initiate communications with HCPs exploiting multichannel digital platforms. Furthermore, pharma companies wishing to improve their HCP engagement strategies need to increase the quality and credibility of content available through digital channels to keep up with the demand by HCPs.

HCPs mostly desire the ability to access educational materials online, including better access to treatment strategies, treatment guidelines, diagnostic tools, journal articles, free trial data, and continuing medical education (CME). With HCP preferences increasingly heading towards digital channels, the ability to source information therein should be an integral part of their workflow. For pharma companies to effectively engage HCPs using digital channels, they should offer creative resources across multiple platforms, making their brand stand out as a source of value.

Strengthening your digital strategies
The key to developing a strong digital strategy is understanding what HCPs need. For one, identify your users’ preferred digital channels and the type of content they want. And here’s a clue: HCPs typically desire more academically-charged content, reliable sources of data, and credible scientific knowledge—not poorly-disguised marketing materials. Most beneficial to physicians is access to genuine and targeted content, along with information management and decision support services.

A great first step for any pharma company wishing to up their digital game is to establish a panel of high quality HCPs. This provides them the opportunity to discuss the specific types of digital content that physicians find valuable to their practice. Pharma marketers should identify the common problems HCPs need answers for, and maintain awareness of changing healthcare landscapes and pressures. In other words, your digital strategies should be flexible and the content should be tailored.

And speaking of content, keep it organized, to the point, and practical – remember HCPs are busy. A robust digital presence should minimally include a website that can host material resources like fact sheets, case studies, and other educational content. The site should also have integrated, on-demand material like streaming presentations and webinars, offer prescribing/diagnostic tools, and facilitate data sharing and other communications.

Monitoring digital engagement
The power of digital healthcare marketing is that it provides an industry rich in data a better way to sample, analyze, and share important clinical information. Herein lies the true potential for digital engagement: it supports innovation and fosters the discovery of critical therapies, which may be developed and delivered quickly and more effectively by exploiting digital technologies. An additional benefit of a strong digital strategy is the ability to track HCP engagement via online discussions, downloads, and more, allowing you to tailor content to what HCPs really want.

Being able to adapt your HCP engagement strategies to better fit your physicians’ needs will position your company and brand as a source of value. With a digital approach, it is possible to report on the progress of an ongoing marketing campaign and change it accordingly. This demonstrates your flexibility and even your credibility as a relevant healthcare company. Ultimately, a digital approach to healthcare marketing will help you form stronger partnerships with HCPs and stakeholders alike, and contribute to your overall market success.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.